Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dentsply Sirona (XRAY) Cash from Investing Activities (2016 - 2025)

Dentsply Sirona (XRAY) has disclosed Cash from Investing Activities for 17 consecutive years, with -$45.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Investing Activities rose 21.05% year-over-year to -$45.0 million, compared with a TTM value of -$132.0 million through Dec 2025, up 32.99%, and an annual FY2025 reading of -$132.0 million, up 32.99% over the prior year.
  • Cash from Investing Activities was -$45.0 million for Q4 2025 at Dentsply Sirona, down from -$36.0 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at -$2.0 million in Q3 2023 and bottomed at -$103.0 million in Q1 2021.
  • Average Cash from Investing Activities over 5 years is -$38.8 million, with a median of -$37.0 million recorded in 2023.
  • The sharpest move saw Cash from Investing Activities skyrocketed 92.31% in 2023, then tumbled 2250.0% in 2024.
  • Year by year, Cash from Investing Activities stood at -$103.0 million in 2021, then surged by 71.84% to -$29.0 million in 2022, then soared by 31.03% to -$20.0 million in 2023, then crashed by 185.0% to -$57.0 million in 2024, then rose by 21.05% to -$45.0 million in 2025.
  • Business Quant data shows Cash from Investing Activities for XRAY at -$45.0 million in Q4 2025, -$36.0 million in Q3 2025, and -$34.0 million in Q2 2025.